Kirklyn Smith puts the Proclaimers to shame… he’s already walked 500 miles, and he’s gonna walk 4,500 more.
The Boise, Idaho office manager has a treadmill built into his desk – a contraption called a TrekDesk – and has a goal to walk 5,000 miles at work in a year. He has launched a website that tracks his trekking progress; so far, he’s at around 3,470 miles walked this year… clearly the runaway champ of any FitBit competition.
Smith has been doing this walking at work thing for more than four years now. He says why on his website:
As a busy professional running the operations of a small office, I found myself letting my excuses get the best of me when time for workouts were no longer convenient. As with many Americans working at a desk, the occasional walk to use the restroom or refill of my coffee cup became the predominant exercise in my day. The infrequent workouts that I would make time for were not enough to offset my love of food and wine. I knew a more earnest commitment needed to be made when I saw a portly picture of myself that was not consistent with the way I visualized my physical appearance.
A familiar tale, no doubt. But now working and walking concurrently has become routine:
A little more than four years later, I’m still walking at the office. I don’t really think about being on a treadmill all day, every day, anymore. It just seems as natural as sitting at a desk when I make my phone calls, type my e-mails, deliver web presentations, visit my reading, and oversee employees. The value, for me, comes in the habit of arriving at the office conditioned to get to work without a second thought paid to exercise or the distance walked the day prior. Exercise ends up being a forgotten byproduct of my everyday workday that takes care of itself. Each day begins like the last day ended… Walking.
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Here’s his set-up. Wow:
